Skip to main content
Equibles
CVRX logo

CVRX · CVRx, Inc. · Metrics

Track CVRX — free

Use CVRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CVRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.42 +0.05 (+3.65%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$37.83M
Shares
26.64M
Volume · Oct 23 199.86K Avg daily vol (3M) 935.51K

CVRX metrics

90 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.42
Market cap
$37.83M

Price action

20 metrics
Price change (1W)
+9.2%
Price change (30D)
-43.9%
Price change (3M)
-70.0%
Price change (6M)
-81.6%
Price change (YTD)
-80.0%
Price change (1Y)
-85.9%
Trailing year
Price change (5Y)
-90.9%
52-week high
$10.81
52-week low
$1.30
Change from 52-week high
-86.9%
Change from 52-week low
+9.2%
Annualized volatility
105.4%
Annualized volatility (3M)
153.7%
Beta
0.9
RSI (14D)
30.5
Price vs SMA 50
-41.0%
Price vs SMA 200
-73.8%
Avg volume (3M)
935,514
Relative volume
0.2
Average dollar volume
$2.38M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
26.64M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.5×
reciprocal yield 192.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 161.7%
P / book
1.9
reciprocal yield 52.7%
FCF yield
-108.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-137.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.1×
reciprocal yield 24.2%
EV / revenue historical average (5Y)
4.5×
reciprocal yield 22.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
86.9%
Operating margin
-79.5%
Trailing 12 months
Net margin
-84.9%
Gross profit (TTM)
$53.18M
Operating profit (TTM)
−$48.64M
Net income (TTM)
−$51.97M
Trailing 12 months
Diluted EPS (TTM)
$-1.97
FCF margin
-67.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$2.33
Gross profit per diluted share (TTM)
$2.02
Operating profit per diluted share (TTM)
$-1.85
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1.97
Operating cash flow per diluted share (TTM)
$-1.54
Free cash flow per diluted share (TTM)
$-1.56
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.47
Stock compensation per diluted share (TTM)
$0.47
Book value per share
$1.49

Growth

11 metrics
Revenue growth YoY
+15.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$61.19M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+36.1%
Revenue CAGR (5Y)
+56.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-260.5%
Return on assets
-56.3%
Debt / equity
2.9
Current ratio
8.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$41.05M
Quick ratio
6.9
Interest coverage
-8.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.01M
Latest balance sheet
Cash & equivalents
$64.59M
Total assets
$92.28M
Total debt
$58.57M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$40.46M
Capital expenditures (TTM)
$597,000
R&D (TTM)
$12.36M
SG&A (TTM)
$89.46M
Stock compensation (TTM)
$12.26M
R&D / revenue
20.2%
Stock compensation / revenue
20.0%

Ownership (13F)

9 metrics
13F filers
88
13F filer change QoQ
-12
Institutional ownership
57.5%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
17.5%
Private-fund adviser ownership
17.0%
Active holders' share change QoQ
+3.6%
Holder tenure
13.8
Price vs estimated holder cost
-45.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.0%

Short interest

3 metrics
Short interest
7.4%
Latest settlement · 2.4 days to cover
Days to cover
2.4d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
$73,094
Insider-sentiment score
82 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1235912 CUSIP 126638105 13F (30d) 7 filings 7 filers Visit website Investor relations